Standard Chartered Bank | Standard Chartered | financial services | economic sanction violation | 2012 | OFAC | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $132,000,000 |
HSBC North America Holdings, Inc. | HSBC | financial services | banking violation | 2016 | FED | $131,000,000 |
Royal Bank of Scotland plc | NatWest Group PLC | financial services | toxic securities abuses | 2015 | NCUA | $129,600,000 |
Royal Bank of Scotland | NatWest Group PLC | financial services | toxic securities abuses | 2017 | CA-AG | $125,000,000 |
Barclays Capital Inc. | Barclays | financial services | investor protection violation | 2022 | SEC | $125,000,000 |
Ernst & Young LLP | Ernst & Young | business services | tax violations | 2013 | USAO | $123,000,000 |
Royal Dutch Petroleum Company | Shell PLC | oil and gas | accounting fraud or deficiencies | 2004 | SEC | $120,000,000 |
RBS Securities, Inc. | NatWest Group PLC | financial services | toxic securities abuses | 2016 | CT-AG | $120,000,000 |
Barclays Bank PLC | Barclays | financial services | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $120,000,000 |
Shell Oil | Shell PLC | oil and gas | environmental violation | 2013 | EPA | $117,600,000 |
Barclays | Barclays | financial services | price-fixing or anti-competitive practices | 2015 | CFTC | $115,000,000 |
Standard Chartered Bank | Standard Chartered | financial services | economic sanction violation | 2012 | NY-MANDA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $113,500,000 |
Shell Oil Company | Shell PLC | oil and gas | False Claims Act and related | 2001 | DOJ_CIVIL | $110,000,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2018 | TX-AG | $110,000,000 |
Ernst & Young | Ernst & Young | business services | accounting fraud or deficiencies | 2009 | MI-AG | $109,000,000 |
Lloyds Banking Group plc | Lloyds Banking Group | financial services | price-fixing or anti-competitive practices | 2014 | CFTC | $105,000,000 |
Barclays Bank PLC | Barclays | financial services | price-fixing or anti-competitive practices | 2017 | FERC | $105,000,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | kickbacks and bribery | 2014 | MULTI-AG | $105,000,000 |
Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | MULTI-AG | $102,500,000 |
BP Energy Company | BP | oil and gas | False Claims Act and related | 2018 | CA-AG | $102,000,000 |
STANDARD CHARTERED PLC | Standard Chartered | financial services | banking violation | 2012 | FED | $100,000,000 |
Janus Capital Management LLC | Janus Henderson | financial services | investor protection violation | 2004 | SEC | $100,000,000 |
HSBC Holdings plc | HSBC | financial services | fraud | 2018 | DOJ_CRIMINAL | $100,000,000 |
Barclays Bank PLC | Barclays | financial services | price-fixing or anti-competitive practices | 2016 | MULTI-AG | $100,000,000 |
Ernst & Young LLP | Ernst & Young | business services | investor protection violation | 2022 | SEC | $100,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $100,000,000 |
HSBC Bank PLC | HSBC | financial services | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $100,000,000 |
RBS Securities Inc. | NatWest Group PLC | financial services | toxic securities abuses | 2014 | FHFA | $99,500,000 |
CF&I Steel, LP, an Oregon Steel Mills Company | Evraz | metals | labor relations violation | 2004 | NLRB | $97,182,500 |
Barclays Capital | Barclays | financial services | investor protection violation | 2017 | SEC | $97,037,659 |
Barclays PLC | Barclays | financial services | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $94,000,000 |
R.J. Reynolds Tobacco Company | British American Tobacco | tobacco | tobacco litigation | 2020 | FL-AG | $92,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $92,000,000 |
Royal Dutch Petroleum Company | Shell PLC | oil and gas | benefit plan administrator violation | 2005 | private lawsuit-federal | $90,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2012 | MULTI-AG | $90,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $90,000,000 |
British Airways PLC | International Airlines Group | airlines | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $89,512,000 |
Barclays Capital Inc. | Barclays | financial services | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $87,000,000 |
Lloyds Banking Group plc | Lloyds Banking Group | financial services | price-fixing or anti-competitive practices | 2014 | DOJ_CRIMINAL | $86,000,000 |
Royal Bank of Scotland plc | NatWest Group PLC | financial services | price-fixing or anti-competitive practices | 2017 | CFTC | $85,000,000 |
BP West Coast Products | BP | oil and gas | environmental violation | 2005 | CA-SCAQMD | $81,000,000 |
BAE Systems plc | BAE Systems | aerospace and military contracting | export control violation | 2011 | DDTC | $79,000,000 |
Coutts & Co Ltd | NatWest Group PLC | financial services | tax violations | 2015 | DOJ_TAX | $78,484,000 |
Barclays Bank PLC | Barclays | financial services | investor protection violation | 2022 | CFTC | $75,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $70,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $70,000,000 |
Brown & Williamson Tobacco Corp. | British American Tobacco | tobacco | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $69,600,000 |
Lorillard Tobacco Co. | British American Tobacco | tobacco | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $69,600,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | $68,500,000 |
Shell Oil Company et al. | Shell PLC | oil and gas | environmental violation | 2018 | NJ-AG | $68,500,000 |
Virgin Atlantic Airways Ltd | Virgin Group | diversified | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $68,000,000 |
Shell Pipeline Company LP | Shell PLC | oil and gas | environmental violation | 2003 | EPA | $67,000,000 |
BP Solar International, Inc. | BP | oil and gas | product safety violation | 2020 | private lawsuit-federal | $67,000,000 |
Balfour Beatty Communities LLC | Balfour Beatty | construction and engineering | False Claims Act and related | 2021 | DOJ_CIVIL | $65,400,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $65,000,000 |
BP America Inc. et al. | BP | oil and gas | environmental violation | 2018 | NJ-AG | $64,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2006 | private lawsuit-state | $63,833,148 |
Shell Oil Company | Shell PLC | oil and gas | environmental violation | 2019 | private lawsuit-state | $63,000,000 |
Terminix International | Rentokil Initial PLC | miscellaneous services | consumer protection violation | 2020 | AL-AG | $60,000,000 |
HSBC | HSBC | financial services | mortgage abuses | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $59,500,000 |
Linde Inc. | Linde | industrial services | energy market violation | 2024 | FERC | $59,000,000 |
Shell Oil | Shell PLC | oil and gas | federal leasing royalty violation | 2000 | DOJ_CIVIL | $56,000,000 |
Royal Bank of Scotland PLC | NatWest Group PLC | financial services | consumer protection violation | 2019 | private lawsuit-federal | $55,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
RBS Financial Products Inc. | NatWest Group PLC | financial services | toxic securities abuses | 2011 | MA-AG | $52,000,000 |
BP America Inc. | BP | oil and gas | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $52,000,000 |
BP Products North America | BP | oil and gas | workplace safety or health violation | 2010 | OSHA | $50,610,000 |
THE ROYAL BANK OF SCOTLAND GROUP PLC | NatWest Group PLC | financial services | banking violation | 2013 | FED | $50,000,000 |
Deloitte & Touche LLP | Deloitte | business services | accounting fraud or deficiencies | 2005 | SEC | $50,000,000 |
Reckitt Benckiser Group plc | Reckitt Benckiser | household and personal care products | price-fixing or anti-competitive practices | 2019 | FTC | $50,000,000 |
Willis Group Holdings Ltd. | Willis Towers Watson | financial services | price-fixing or anti-competitive practices | 2005 | NY-AG | $50,000,000 |
Royal Bank of Scotland | NatWest Group PLC | financial services | economic sanction violation | 2013 | NY-DFS | $50,000,000 |
Cristal USA, Inc. | Ineos | chemicals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $50,000,000 |
Royal Bank of Scotland PLC | NatWest Group PLC | financial services | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $50,000,000 |
Reckitt Benckiser LLC | Reckitt Benckiser | household and personal care products | consumer protection violation | 2021 | private lawsuit-federal | $50,000,000 |
Shell Oil Company | Shell PLC | oil and gas | False Claims Act and related | 2003 | DOJ_CIVIL | $49,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $49,000,000 |
SmithKline Beecham | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
Household International | HSBC | financial services | benefit plan administrator violation | 2004 | private lawsuit-federal | $46,500,000 |
AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
BP-ARCO | BP | oil and gas | environmental violation | 2002 | CA-AG | $45,800,000 |
HSBC Holdings PLC | HSBC | financial services | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $45,000,000 |
HSBC Bank USA, N.A. | HSBC | financial services | investor protection violation | 2023 | CFTC | $45,000,000 |
RBS Securities Inc. | NatWest Group PLC | financial services | toxic securities abuses | 2017 | USAO | $44,000,000 |
RBS Financial Products | NatWest Group PLC | financial services | toxic securities abuses | 2012 | NV-AG | $42,000,000 |
HSBC Bank PLC | HSBC | financial services | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $42,000,000 |
British Airways PLC | International Airlines Group | airlines | consumer protection violation | 2018 | private lawsuit-federal | $42,000,000 |
PriceWaterhouseCoopers, LLP | PricewaterhouseCoopers | business services | False Claims Act and related | 2005 | DOJ_CIVIL | $41,900,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
Ernst & Young | Ernst & Young | business services | banking violation | 2004 | FDIC | $40,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
Standard Chartered Bank | Standard Chartered | financial services | price-fixing or anti-competitive practices | 2019 | NY-DFS | $40,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2008 | private lawsuit-federal | $40,000,000 |
National Grid USA | National Grid | utilities and power generation | privacy violation | 2022 | private lawsuit-federal | $38,500,000 |
BP PRODUCTS NORTH AMERICA INC | BP | oil and gas | environmental violation | 2023 | EPA | $36,424,000 |
Barclays Bank PLC | Barclays | financial services | toxic securities abuses | 2013 | MA-AG | $36,100,000 |
HSBC Bank USA, National Association | HSBC | financial services | banking violation | 2016 | OCC | $35,000,000 |
Barclays Capital Inc. | Barclays | financial services | investor protection violation | 2016 | SEC | $35,000,000 |
Aegerion Pharmaceuticals Inc. | Amryt Pharma | pharmaceuticals | drug or medical equipment safety violation | 2017 | DOJ_CIVIL | $35,000,000 |